Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pelz

Showing results (761-770 of 835) with videos related to

Pageof 84
Sort By:
The Lancet. Oncology|April 11, 2022
De-escalated neoadjuvant pertuzumab plus trastuzumab therapy with or without weekly paclitaxel in HER2-positive, hormone receptor-negative, early breast cancer (WSG-ADAPT-HER2+/HR-): survival outcomes from a multicentre, open-label, randomised, phase 2 trialUlrike Nitz, Oleg Gluz, Monika Graeser, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 3, 2025
Multiomic Factor Analysis for Pathologic Complete Response after Pembrolizumab + Trastuzumab + Pertuzumab in HER2-Enriched Early Breast Cancer: WSG-Keyriched-1 TrialMonika Graeser, Oleg Gluz, Peter Schmid, et al.
Cancer Research|September 18, 2025
The Prolyl Isomerase PIN1 Affects Fibroblast Differentiation States and Cross-talk in Pancreatic CancerChloe L Bowman, Colin J Daniel, Eric J Carlson, et al.
Molecular and Cellular Biology|June 15, 2022
The RNA-Binding Protein HuR Posttranscriptionally Regulates the Protumorigenic Activator YAP1 in Pancreatic Ductal AdenocarcinomaSamantha Z Brown, Grace A McCarthy, James R Carroll, et al.
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|May 26, 2017
Registries on peritoneal surface malignancies throughout the world, their use and their optionsVictor J Verwaal, Beate Rau, Faek Jamali, et al.
Journal of the American Chemical Society|October 3, 2025
Kinetically Controlled Seed-Mediated Synthesis of Colloidal Copper Nanotetrahedra with Intricate Internal StructureSoojin Jeong, Mingjian Wu, Rebecca X Skalla, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|September 20, 2008
The impact of individual and methodological factors in the variability of response to methylphenidate in ADHD pharmacogenetic studies from four different continentsGuilherme Polanczyk, Stephen V Faraone, Claiton H D Bau, et al.
Pharmaceutics|December 23, 2023
Micelle-Formulated Juglone Effectively Targets Pancreatic Cancer and Remodels the Tumor MicroenvironmentVidhi M Shah, Syed Rizvi, Alexander Smith, et al.
Chemmedchem|January 11, 2016
Identification and Optimization of Anthranilic Acid Based Inhibitors of Replication Protein AJames D Patrone, Nicholas F Pelz, Brittney S Bates, et al.
Molecular Cancer|March 27, 2025
Immunomodulatory gene networks predict treatment response and survival to de-escalated, anthracycline-free neoadjuvant chemotherapy in triple-negative breast cancer in the WSG-ADAPT-TN trialDarren Korbie, Clare Stirzaker, Oleg Gluz, et al.
Pageof 84

Showing results (761-770 of 835) with videos related to

Sort By:
Pageof 84
The Lancet. Oncology|April 11, 2022
De-escalated neoadjuvant pertuzumab plus trastuzumab therapy with or without weekly paclitaxel in HER2-positive, hormone receptor-negative, early breast cancer (WSG-ADAPT-HER2+/HR-): survival outcomes from a multicentre, open-label, randomised, phase 2 trialUlrike Nitz, Oleg Gluz, Monika Graeser, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 3, 2025
Multiomic Factor Analysis for Pathologic Complete Response after Pembrolizumab + Trastuzumab + Pertuzumab in HER2-Enriched Early Breast Cancer: WSG-Keyriched-1 TrialMonika Graeser, Oleg Gluz, Peter Schmid, et al.
Cancer Research|September 18, 2025
The Prolyl Isomerase PIN1 Affects Fibroblast Differentiation States and Cross-talk in Pancreatic CancerChloe L Bowman, Colin J Daniel, Eric J Carlson, et al.
Molecular and Cellular Biology|June 15, 2022
The RNA-Binding Protein HuR Posttranscriptionally Regulates the Protumorigenic Activator YAP1 in Pancreatic Ductal AdenocarcinomaSamantha Z Brown, Grace A McCarthy, James R Carroll, et al.
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|May 26, 2017
Registries on peritoneal surface malignancies throughout the world, their use and their optionsVictor J Verwaal, Beate Rau, Faek Jamali, et al.
Journal of the American Chemical Society|October 3, 2025
Kinetically Controlled Seed-Mediated Synthesis of Colloidal Copper Nanotetrahedra with Intricate Internal StructureSoojin Jeong, Mingjian Wu, Rebecca X Skalla, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|September 20, 2008
The impact of individual and methodological factors in the variability of response to methylphenidate in ADHD pharmacogenetic studies from four different continentsGuilherme Polanczyk, Stephen V Faraone, Claiton H D Bau, et al.
Pharmaceutics|December 23, 2023
Micelle-Formulated Juglone Effectively Targets Pancreatic Cancer and Remodels the Tumor MicroenvironmentVidhi M Shah, Syed Rizvi, Alexander Smith, et al.
Chemmedchem|January 11, 2016
Identification and Optimization of Anthranilic Acid Based Inhibitors of Replication Protein AJames D Patrone, Nicholas F Pelz, Brittney S Bates, et al.
Molecular Cancer|March 27, 2025
Immunomodulatory gene networks predict treatment response and survival to de-escalated, anthracycline-free neoadjuvant chemotherapy in triple-negative breast cancer in the WSG-ADAPT-TN trialDarren Korbie, Clare Stirzaker, Oleg Gluz, et al.
Pageof 84